KAPA
Kairos Pharma, LTD.
Pharmaceutical PreparationsNYSENon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Total Trades
3
Buys
3
Sells
0
Largest Trade
$1K–$15K
Insiders
3
Institutional Funds
7
Inst. Value
$100K–$500K
Activist Filings
2
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Murali Ramachandran | VP of Research and… | BUY | <$1K | 200 | $1.59 | Nov 26, 2024 |
| Samuelson Doug | CFO | BUY | $1K–$15K | 3K | $1.50 | Nov 25, 2024 |
| Yu John S | CEO and Chairman | BUY | $1K–$15K | 4K | $1.44 | Nov 22, 2024 |
🔓Seeing ranges? Sign in for exact trade values — free forever
Institutional Ownership
13F filings as of Dec 31, 2025 · 7 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| VANGUARD GROUP INC | 68K | $15K–$50K | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 68K | $15K–$50K | SH |
| SevenBridge Financial Group, LLC | 44K | $15K–$50K | SH |
| Aptus Capital Advisors, LLC | 44K | $15K–$50K | SH |
| STATE STREET CORP | 24K | $15K–$50K | SH |
| HRT FINANCIAL LP | 21K | $15K–$50K | SH |
| Virtu Financial LLC | 20K | $1K–$15K | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G/A · Aug 15, 2025
5.0%
885K shares
SC 13G · May 15, 2025
10.0%
1.7M shares